Lista de obras - Adolfo Favaretto - Dominio Público Uruguay

A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial

artículo científico publicado en 2017

A pathological complete response after preoperative chemotherapy with carboplatin and pemetrexed in malignant pleural mesothelioma: A case report

artículo científico publicado en 2010

A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors

artículo científico publicado en 2014

Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study

artículo científico publicado en 2006

Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study

artículo científico publicado en 2014

An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesothelioma.

artículo científico

Bone marrow myeloid cell kinetics during treatment of small cell carcinoma of the lung with chemotherapy not associated and associated with granulocyte-macrophage colony-stimulating factor

artículo científico publicado en 1993

Changes in pulmonary function tests predict radiological response to chemotherapy in malignant pleural mesothelioma.

artículo científico publicado en 2013

Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies

artículo científico publicado en 2007

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.

artículo científico publicado en 2004

Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm

artículo científico publicado en 1990

Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations

artículo científico publicado en 2017

Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancer.

artículo científico publicado en 2016

Critical review about MDM2 in cancer: Possible role in malignant mesothelioma and implications for treatment

artículo científico

Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial

artículo científico publicado en 2014

EAGLES study: First-line Bevacizumab in Combination with Chemotherapy in Elderly Patients with Advanced, Metastatic, Non-squamous Non-small Cell Lung Cancer

artículo científico publicado en 2017

Effect of induction chemotherapy on lung function and exercise capacity in patients affected by malignant pleural mesothelioma

artículo científico publicado en 2010

Effects of sulfonylureas on tumor growth: a review of the literature

artículo científico publicado en 2013

Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial

artículo científico publicado en 2017

First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial

artículo científico publicado en 2012

Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study

artículo científico publicado en 2003

HLA-G 3'UTR Polymorphisms Predict Drug-Induced G3-4 Toxicity Related to Folinic Acid/5-Fluorouracil/Oxaliplatin (FOLFOX4) Chemotherapy in Non-Metastatic Colorectal Cancer.

artículo científico publicado en 2017

Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): Feasibility and results

artículo científico publicado en 2007

LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab

artículo científico publicado en 2017

Long term results of surgery and chemotherapy in small cell lung cancer

artículo científico publicado en 1998

Long-term survival and prognostic factors in thymic epithelial tumours

scientific article published on 01 August 2004

MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data

artículo científico publicado en 2015

Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors and new therapeutic perspectives in non small cell lung cancer.

artículo científico publicado en 2011

Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker woman.

artículo científico publicado en 2016

Multidisciplinary approach for advanced stage thymic tumors: long-term outcome

scientific article published on 12 August 2010

Non-Small Cell Lung Cancer in a Very Young Woman: A Case Report and Critical Review of the Literature

artículo científico publicado en 2015

Nondisruptive p53 mutations are associated with shorter survival in patients with advanced non-small cell lung cancer.

artículo científico publicado en 2014

Nonmyeloablative allogeneic stem cell transplantation (NST) after truly nonmyeloablative and reduced intensity conditioning regimens

artículo científico publicado en 2004

Oral vinorelbine plus cisplatin as first-line chemotherapy in nonsquamous non-small-cell lung cancer: final results of an International randomized phase II study (NAVotrial 01).

artículo científico publicado en 2014

Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.

artículo científico publicado en 2014

Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials.

artículo científico publicado en 2008

Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study.

artículo científico publicado en 2007

Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trial

artículo científico publicado en 2012

Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients.

artículo científico publicado en 2001

Phase II randomized study of vandetanib plus gemcitabine or gemcitabine plus placebo as first-line treatment of advanced non-small-cell lung cancer in elderly patients.

artículo científico publicado en 2014

Phase II study of afatinib, an irreversible ErbB family blocker, in EGFR FISH-positive non-small-cell lung cancer.

artículo científico publicado en 2015

Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma

artículo científico publicado en 2006

Phase III Multinational, Randomized, Double-Blind, Placebo-Controlled Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Erlotinib Alone in Previously Treated Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-Cell Lung Cancer.

artículo científico publicado en 2015

Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience

artículo científico publicado en 2011

Platinum-etoposide chemotherapy in elderly patients with small-cell lung cancer: results of a randomized multicenter phase II study assessing attenuated-dose or full-dose with lenograstim prophylaxis--a Forza Operativa Nazionale Italiana Carcinoma P

artículo científico publicado en 2005

Pre-operative chemoradiotherapy in non-small cell lung cancer stage III patients. Feasibility, toxicity and long-term results of a phase II study.

artículo científico publicado en 1996

Preoperative concomitant chemo-radiotherapy in superior sulcus tumour: A mono-institutional experience.

artículo científico publicado en 2009

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the eld

artículo científico publicado en 2005

Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey

artículo científico publicado en 2014

Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials

artículo científico publicado en 2012

Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer

artículo científico publicado en 2012

Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment

scientific article published on 21 June 2016

Randomized phase III PITCAP trial and meta-analysis of induction chemotherapy followed by thoracic irradiation with or without concurrent taxane-based chemotherapy in locally advanced NSCLC.

artículo científico publicado en 2016

Rationale and design of MILES-3 and MILES-4 studies: two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non--small-cell lung cancer

artículo científico publicado en 2013

Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience.

artículo científico publicado en 2012

Results of surgical resection after induction chemoradiation for Pancoast tumours †.

artículo científico publicado en 2015

Second and third responses to the same induction regimen in relapsing patients with multiple myeloma

artículo científico publicado en 1991

Single-agent pemetrexed or sequential pemetrexed/gemcitabine as front-line treatment of advanced non-small cell lung cancer in elderly patients or patients ineligible for platinum-based chemotherapy: a multicenter, randomized, phase II trial

artículo científico publicado en 2007

Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study.

artículo científico publicado en 2011

Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterization

artículo científico publicado en 2016

Stanford V regimen plus consolidative radiotherapy is an effective therapeutic program for bulky or advanced-stage Hodgkin's disease

artículo científico publicado en 2004

Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials

artículo científico publicado en 2015

Synergistic antitumor activity of recombinant human Apo2L/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in combination with carboplatin and pemetrexed in malignant pleural mesothelioma

artículo científico publicado en 2014

The predictive value of BRCA1 and RAP80 mRNA expression in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy

artículo científico publicado en 2013

The surgeon and the oncologist in non-small cell lung cancer (NSCLC).

artículo científico publicado en 2006

Treatment of Unfit Patients With Advanced Non-Small-Cell Lung Cancer: Definition Criteria According an Expert Panel.

artículo científico

Ultrarapid high-dose course of prophylactic cranial irradiation in small-cell lung cancer: evaluation of late neurologic morbidity in 16 long-term survivors

artículo científico publicado en 1998

Lista de obras de Adolfo Favaretto

A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial

A pathological complete response after preoperative chemotherapy with carboplatin and pemetrexed in malignant pleural mesothelioma: A case report

A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors

Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study

Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study

An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesothelioma.

Bone marrow myeloid cell kinetics during treatment of small cell carcinoma of the lung with chemotherapy not associated and associated with granulocyte-macrophage colony-stimulating factor

Changes in pulmonary function tests predict radiological response to chemotherapy in malignant pleural mesothelioma.

Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.

Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm

Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations

Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancer.

Critical review about MDM2 in cancer: Possible role in malignant mesothelioma and implications for treatment

Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial

EAGLES study: First-line Bevacizumab in Combination with Chemotherapy in Elderly Patients with Advanced, Metastatic, Non-squamous Non-small Cell Lung Cancer

Effect of induction chemotherapy on lung function and exercise capacity in patients affected by malignant pleural mesothelioma

Effects of sulfonylureas on tumor growth: a review of the literature

Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial

First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial

Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study

HLA-G 3'UTR Polymorphisms Predict Drug-Induced G3-4 Toxicity Related to Folinic Acid/5-Fluorouracil/Oxaliplatin (FOLFOX4) Chemotherapy in Non-Metastatic Colorectal Cancer.

Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): Feasibility and results

LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab

Long term results of surgery and chemotherapy in small cell lung cancer

Long-term survival and prognostic factors in thymic epithelial tumours

MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data

Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors and new therapeutic perspectives in non small cell lung cancer.

Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker woman.

Multidisciplinary approach for advanced stage thymic tumors: long-term outcome

Non-Small Cell Lung Cancer in a Very Young Woman: A Case Report and Critical Review of the Literature

Nondisruptive p53 mutations are associated with shorter survival in patients with advanced non-small cell lung cancer.

Nonmyeloablative allogeneic stem cell transplantation (NST) after truly nonmyeloablative and reduced intensity conditioning regimens

Oral vinorelbine plus cisplatin as first-line chemotherapy in nonsquamous non-small-cell lung cancer: final results of an International randomized phase II study (NAVotrial 01).

Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.

Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials.

Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study.

Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trial

Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients.

Phase II randomized study of vandetanib plus gemcitabine or gemcitabine plus placebo as first-line treatment of advanced non-small-cell lung cancer in elderly patients.

Phase II study of afatinib, an irreversible ErbB family blocker, in EGFR FISH-positive non-small-cell lung cancer.

Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma

Phase III Multinational, Randomized, Double-Blind, Placebo-Controlled Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Erlotinib Alone in Previously Treated Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-Cell Lung Cancer.

Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience

Platinum-etoposide chemotherapy in elderly patients with small-cell lung cancer: results of a randomized multicenter phase II study assessing attenuated-dose or full-dose with lenograstim prophylaxis--a Forza Operativa Nazionale Italiana Carcinoma P

Pre-operative chemoradiotherapy in non-small cell lung cancer stage III patients. Feasibility, toxicity and long-term results of a phase II study.

Preoperative concomitant chemo-radiotherapy in superior sulcus tumour: A mono-institutional experience.

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the eld

Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey

Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials

Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer

Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment

Randomized phase III PITCAP trial and meta-analysis of induction chemotherapy followed by thoracic irradiation with or without concurrent taxane-based chemotherapy in locally advanced NSCLC.

Rationale and design of MILES-3 and MILES-4 studies: two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non--small-cell lung cancer

Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience.

Results of surgical resection after induction chemoradiation for Pancoast tumours †.

Second and third responses to the same induction regimen in relapsing patients with multiple myeloma

Single-agent pemetrexed or sequential pemetrexed/gemcitabine as front-line treatment of advanced non-small cell lung cancer in elderly patients or patients ineligible for platinum-based chemotherapy: a multicenter, randomized, phase II trial

Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study.

Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterization

Stanford V regimen plus consolidative radiotherapy is an effective therapeutic program for bulky or advanced-stage Hodgkin's disease

Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials

Synergistic antitumor activity of recombinant human Apo2L/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in combination with carboplatin and pemetrexed in malignant pleural mesothelioma

The predictive value of BRCA1 and RAP80 mRNA expression in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy

The surgeon and the oncologist in non-small cell lung cancer (NSCLC).

Treatment of Unfit Patients With Advanced Non-Small-Cell Lung Cancer: Definition Criteria According an Expert Panel.

Ultrarapid high-dose course of prophylactic cranial irradiation in small-cell lung cancer: evaluation of late neurologic morbidity in 16 long-term survivors